发明名称 Compounds, compositions and methods
摘要 Certain substituted urea derivatives selectively modulate the cardiac sarcomere, for example by potentiating cardiac myosin, and are useful in the treatment of systolic heart failure including congestive heart failure.
申请公布号 US9150564(B2) 申请公布日期 2015.10.06
申请号 US201414489705 申请日期 2014.09.18
申请人 CYTOKINETICS, INC. 发明人 Morgan Bradley Paul;Muci Alex;Lu Pu-Ping;Kraynack Erica Anne;Tochimoto Todd;Morgans, Jr. David J.
分类号 A61K31/54;A61K31/535;A61K31/44;A61K31/445;A61K31/497;C07D417/12;C07D401/12;C07D213/75;C07D211/56;C07D239/42;C07D261/14;C07D263/48;C07D271/113;C07D295/26;C07D401/10;C07D417/10;C07D487/04;C07D491/04;C07D513/04;C07D417/00 主分类号 A61K31/54
代理机构 Marshall Gerstein & Borun LLP 代理人 Marshall Gerstein & Borun LLP
主权项 1. A method of increasing cardiac contractility of cardiac tissue without changing the calcium transient comprising contacting the cardiac tissue with methyl-4-(2-fluoro-3-(6-methylpyridin-3-yl)benzyl)piperazine-1-carboxylate having the structure:or a pharmaceutically acceptable salt thereof.
地址 South San Francisco CA US